Dodging matrix effects in liquid chromatography tandem mass spectrometric assays—compilation of key learnings and perspectives |
| |
Authors: | Nuggehally R. Srinivas |
| |
Affiliation: | Global Drug Development, ClinTec (India) International Pvt Ltd, 3rd Floor ‘A’ Wing, Langford Road, Bangalore 560 025, India |
| |
Abstract: | Triple quad liquid chromatography mass spectrometric assays (LC/MS/MS) have revolutionized the analysis of drug(s)/metabolite(s) with exceptional speed, sensitivity and selectivity features. From inception to date, several new and innovative features have been regularly proposed by researchers to further enhance the value in the applicability of this analytical tool. However, owing to such compressed run times and scanty sample preparation procedures, LC/MS/MS assays that are not fully optimized generally have issues of matrix effects, where ionization potential is either suppressed or enhanced due to the presence of other materials (endogenous/exogenous) in the matrix. By definition, even co‐medications, isomeric or isobaric impurities, and drug excipients used in dosing solutions could also potentially contribute to matrix effects. This article captures some of the interesting work carried out by researchers to understand and handle matrix effects. Additionally, it provides perspectives to effectively deal with matrix effects. Copyright © 2008 John Wiley & Sons, Ltd. |
| |
Keywords: | LC/MS/MS matrix effect assay validation plasma |
|
|